Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bertucci

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancerC Protière, P Viens, D Genre, et al.
Oncogene|November 23, 2011
Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasisJ Gillibert-Duplantier, B Duthey, V Sisirak, et al.
ESMO Open|October 5, 2025
Expression of antibody-drug conjugate targets in soft tissue sarcomasF Bertucci, P Finetti, L Mescam, et al.
Bulletin Du Cancer|April 21, 2001
[Molecular typing of breast cancer: transcriptomics and DNA microarrays]F Bertucci, R Houlgatte, C Nguyen, et al.
Human Molecular Genetics|December 15, 2000
Gene expression profiling of primary breast carcinomas using arrays of candidate genesF Bertucci, R Houlgatte, A Benziane, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcomaF Bertucci, A De Nonneville, P Finetti, et al.
Leukemia|June 18, 2010
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignanciesJ Adélaïde, V Gelsi-Boyer, J Rocquain, et al.
Bone Marrow Transplantation|August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancerP Viens, G Gravis, D Genre, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancerC Protière, P Viens, D Genre, et al.
Oncogene|November 23, 2011
Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasisJ Gillibert-Duplantier, B Duthey, V Sisirak, et al.
ESMO Open|October 5, 2025
Expression of antibody-drug conjugate targets in soft tissue sarcomasF Bertucci, P Finetti, L Mescam, et al.
Bulletin Du Cancer|April 21, 2001
[Molecular typing of breast cancer: transcriptomics and DNA microarrays]F Bertucci, R Houlgatte, C Nguyen, et al.
Human Molecular Genetics|December 15, 2000
Gene expression profiling of primary breast carcinomas using arrays of candidate genesF Bertucci, R Houlgatte, A Benziane, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcomaF Bertucci, A De Nonneville, P Finetti, et al.
Leukemia|June 18, 2010
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignanciesJ Adélaïde, V Gelsi-Boyer, J Rocquain, et al.
Bone Marrow Transplantation|August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancerP Viens, G Gravis, D Genre, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
Pageof 12